Follow-On Biologics Law “Inevitable,” Sen. Hatch Says; BIO Must “Engage”

Legislation creating a follow-on biologics approval pathway is inevitable, Sen. Orrin Hatch (R-Utah) said at the conclusion of a June 23 Judiciary Committee hearing

More from Archive

More from Pink Sheet